Exane Derivatives’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-7,700
| Closed | -$337K | – | 716 |
|
|
2020
Q1 | $337K | Buy |
+7,700
| New | +$337K | 0.09% | 136 |
|
|
2018
Q4 | – | Sell |
-1,000
| Closed | -$44.5K | – | 691 |
|
|
2018
Q3 | $44.5K | Buy |
+1,000
| New | +$44.5K | 0.01% | 352 |
|
|
2017
Q3 | – | Sell |
-14,473
| Closed | -$693K | – | 594 |
|
|
2017
Q2 | $693K | Buy |
14,473
+12,104
| +511% | +$580K | 0.15% | 97 |
|
|
2017
Q1 | $107K | Buy |
2,369
+1,598
| +207% | +$72.3K | 0.02% | 209 |
|
|
2016
Q4 | $31.2K | Buy |
+771
| New | +$31.2K | 0.01% | 299 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 602 |
|
|
2016
Q1 | – | Sell |
-13,721
| Closed | -$585K | – | 550 |
|
|
2015
Q4 | $585K | Buy |
13,721
+7,867
| +134% | +$336K | 0.08% | 93 |
|
|
2015
Q3 | $278K | Buy |
+5,854
| New | +$278K | 0.04% | 142 |
|